HDAC9 and neuroblastoma: Since the histone deacetylase (HDAC) inhibitor vorinostat that inhibits MIF [100] induces cell death in NB cell lines [101], we have recently performed an in silico analysis in order to investigate the potential involvement of MIF and DDT modulation in the in vitro anticancer activity of this drug in NB patients [57].